Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis

Eur Respir J. 2012 Mar;39(3):777-80. doi: 10.1183/09031936.00076711.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoantibodies / blood
  • Autoantibodies / immunology*
  • Autoimmune Diseases / blood
  • Autoimmune Diseases / immunology*
  • Bronchoalveolar Lavage Fluid / chemistry
  • Bronchoalveolar Lavage Fluid / immunology
  • Clinical Trials, Phase II as Topic
  • Granulocyte-Macrophage Colony-Stimulating Factor / immunology
  • Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Lung / drug effects
  • Lung / physiopathology
  • Macrophages, Alveolar / drug effects
  • Macrophages, Alveolar / immunology
  • Multicenter Studies as Topic
  • Oxygen / blood
  • Pulmonary Alveolar Proteinosis / blood
  • Pulmonary Alveolar Proteinosis / immunology*
  • Pulmonary Alveolar Proteinosis / physiopathology
  • Retrospective Studies

Substances

  • Autoantibodies
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Oxygen